HROW position history
The shares of Harrow Health (HROW) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 3,285,000 shares, $30M, 5.6% of portfolio
- 2021 Q4: 3,285,000 shares, $28M, 6.0% of portfolio
- 2022 Q1: 3,291,343 shares, $22M, 7.0% of portfolio, Add +0.2%
- 2022 Q2: 3,332,732 shares, $24M, 10.9% of portfolio, Add +1.3%
- 2022 Q3: 3,343,817 shares, $40M, 16.7% of portfolio, Add +0.3%
- 2022 Q4: 3,775,000 shares, $56M, 19.4% of portfolio, Add +12.9%
- 2023 Q1: 3,775,000 shares, $80M, 23.9% of portfolio
- 2023 Q2: 3,775,000 shares, $72M, 17.2% of portfolio
- 2023 Q3: 3,795,000 shares, $55M, 17.7% of portfolio, Add +0.5%
- 2023 Q4: 3,820,000 shares, $43M, 11.4% of portfolio, Add +0.7%
- 2024 Q1: 7,841,200 shares, $104M, 23.2% of portfolio, Add +105.3%
- 2024 Q2: 3,990,000 shares, $83M, 19.0% of portfolio, Reduce −49.1%
- 2024 Q3: 3,990,000 shares, $179M, 29.9% of portfolio
- 2024 Q4: 3,990,000 shares, $134M, 23.4% of portfolio
- 2025 Q1: 3,955,000 shares, $105M, 23.4% of portfolio, Reduce −0.9%
- 2025 Q2: 7,810,000 shares, $239M, 48.0% of portfolio, Add +97.5%
- 2025 Q3: 3,905,000 shares, $188M, 26.6% of portfolio, Reduce −50.0%
- 2025 Q4: 7,810,000 shares, $383M, 50.5% of portfolio, Add +100.0%
- 2026 Q1: 2,832,230 shares, $100M, 13.2% of portfolio, Reduce −63.7%
- 2026 Q2: 2,400,000 shares, $102M, 9.2% of portfolio, Reduce −15.3%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|